wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q30317067-01F94E42-F72D-447F-87D1-12DCAF170C80
Q30317067-01F94E42-F72D-447F-87D1-12DCAF170C80
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30317067-01F94E42-F72D-447F-87D1-12DCAF170C80
ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)†
P2860
Q30317067-01F94E42-F72D-447F-87D1-12DCAF170C80
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30317067-01F94E42-F72D-447F-87D1-12DCAF170C80
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
78d615b76a6f11ed7a9d2381742e3f1a242f9f09
P2860
Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, mult